COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2020

COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

(1, 2) , (3, 4) , (1) , (4) , (1, 2)
1
2
3
4
Fichier principal
Vignette du fichier
PIIS0959804920301933.pdf (1016.17 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

inserm-02565846 , version 1 (06-05-2020)

Identifiers

Cite

Alessandro Leonetti, Francesco Facchinetti, Teresa Zielli, Elena Brianti, Marcello Tiseo. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors. European Journal of Cancer, 2020, 132, pp.122-124. ⟨10.1016/j.ejca.2020.04.004⟩. ⟨inserm-02565846⟩
89 View
116 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More